The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Natural-product-derived fragments for fragment-based ligand discovery
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural products as sources of new drugs over the 30 years from 1981 to 2010
Newman, D. J., & Cragg, G. M. (2012) · Journal of Natural Products · doi:10.1021/np200906s · Cited by 4,687
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Lovering, F., Bikker, J., & Humblet, C. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901241e · Cited by 4,495
ZINC: A Free Tool to Discover Chemistry for Biology
Irwin, J. J., Sterling, T., Mysinger, M. M., Bolstad, E. S., & Coleman, R. G. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci3001277 · Cited by 2,509
The Properties of Known Drugs. 1. Molecular Frameworks
Bemis, G. W., & Murcko, M. A. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9602928 · Cited by 2,482
A ‘Rule of Three’ for fragment-based lead discovery?
Congreve, M., Carr, R., Murray, C., & Jhoti, H. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02831-9 · Cited by 1,354
The rise of fragment-based drug discovery
Murray, C. W., & Rees, D. C. (2009) · Nature Chemistry · doi:10.1038/nchem.217 · Cited by 791
Butina, D. (1999) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci9803381 · Cited by 601
Koch, M. A., Schuffenhauer, A., Scheck, M., Wetzel, S., Casaulta, M., Odermatt, A., Ertl, P., & Waldmann, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503647102 · Cited by 544
Self-citationWetzel, S., Bon, R. S., Kumar, K., & Waldmann, H. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201007004 · Cited by 505
Self-citationSteinbeck, C., Hoppe, C., Kuhn, S., Floris, M., Guha, R., & Willighagen, E. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777585274 · Cited by 462
Ritchie, T. J., Macdonald, S. J. F., Young, R. J., & Pickett, S. D. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2010.11.014 · Cited by 442
Inhibitors of Protein Tyrosine Phosphatases: Next‐Generation Drugs?
Bialy, L., & Waldmann, H. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200461517 · Cited by 420
Self-citationThe Scaffold Tree − Visualization of the Scaffold Universe by Hierarchical Scaffold Classification
Schuffenhauer, A., Ertl, P., Roggo, S., Wetzel, S., Koch, M. A., & Waldmann, H. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci600338x · Cited by 364
Self-citationMolecular Shape and Medicinal Chemistry: A Perspective
Nicholls, A., McGaughey, G. B., Sheridan, R. P., Good, A. C., Warren, G., Mathieu, M., Muchmore, S. W., Brown, S. P., Grant, J. A., Haigh, J. A., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm900818s · Cited by 310
Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis
Nören-Müller, A., Reis-Corrêa, I., Prinz, H., Rosenbaum, C., Saxena, K., Schwalbe, H. J., Vestweber, D., Cagna, G., Schunk, S., Schwarz, O., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601490103 · Cited by 303
Self-citationSynthesis of Natural Product Inspired Compound Collections
Kumar, K., & Waldmann, H. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200803437 · Cited by 301
Self-citationRoute to three-dimensional fragments using diversity-oriented synthesis
Hung, A. W., Ramek, A., Wang, Y., Kaya, T., Wilson, J. A., Clemons, P. A., & Young, D. W. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015271108 · Cited by 268
Bioactivity-Guided Navigation of Chemical Space
Bon, R. S., & Waldmann, H. (2010) · Accounts of Chemical Research · doi:10.1021/ar100014h · Cited by 245
Self-citationInteractive exploration of chemical space with Scaffold Hunter
Wetzel, S., Klein, K., Renner, S., Rauh, D., Oprea, T. I., Mutzel, P., & Waldmann, H. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.187 · Cited by 228
Self-citationQuantifying biogenic bias in screening libraries
Hert, J., Irwin, J. J., Laggner, C., Keiser, M. J., & Shoichet, B. K. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.180 · Cited by 222
Scaffold diversity of natural products: inspiration for combinatorial library design
Grabowski, K., Baringhaus, K.-H., & Schneider, G. (2008) · Natural Product Reports · doi:10.1039/b715668p · Cited by 218
From fragment to clinical candidate—a historical perspective
Chessari, G., & Woodhead, A. J. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.04.007 · Cited by 202
Identification of Novel p38α MAP Kinase Inhibitors Using Fragment-Based Lead Generation
Gill, A. L., Frederickson, M., Cleasby, A., Woodhead, S. J., Carr, M. G., Woodhead, A. J., Walker, M. T., Congreve, M. S., Devine, L. A., Tisi, D., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049575n · Cited by 186
Deconstructing fragment-based inhibitor discovery
Babaoglu, K., & Shoichet, B. K. (2006) · Nature Chemical Biology · doi:10.1038/nchembio831 · Cited by 162
The therapeutic potential of phosphatase inhibitors
Vintonyak, V. V., Antonchick, A. P., Rauh, D., & Waldmann, H. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.03.021 · Cited by 153
Self-citationBiology-inspired synthesis of compound libraries
Kaiser, M., Wetzel, S., Kumar, K., & Waldmann, H. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7492-1 · Cited by 148
Self-citationA new screening assay for allosteric inhibitors of cSrc
Simard, J. R., Klüter, S., Grütter, C., Getlik, M., Rabiller, M., Rode, H. B., & Rauh, D. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.162 · Cited by 144
Self-citationBioactivity-guided mapping and navigation of chemical space
Renner, S., van Otterlo, W. A. L., Domínguez, M., Möcklinghoff, S., Hofmann, B., Wetzel, S., Schuffenhauer, A., Ertl, P., Oprea, T. I., Steinhilber, D., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.188 · Cited by 140
Self-citationCheminformatic Analysis of Natural Products and their Chemical Space
Wetzel, S., Schuffenhauer, A., Roggo, S. P., Ertl, P., & Waldmann, H. (2007) · CHIMIA International Journal for Chemistry · doi:10.2533/chimia.2007.355 · Cited by 123
Self-citationKöster, H., Craan, T., Brass, S., Herhaus, C., Zentgraf, M., Neumann, L., Heine, A., & Klebe, G. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200642w · Cited by 117
Proteus in the World of Proteins: Conformational Changes in Protein Kinases
Rabiller, M., Getlik, M., Klüter, S., Richters, A., Tückmantel, S., Simard, J. R., & Rauh, D. (2010) · Archiv der Pharmazie · doi:10.1002/ardp.201000028 · Cited by 98
Self-citationEvaluation of (+)-Sparteine-like Diamines for Asymmetric Synthesis
Dearden, M. J., McGrath, M. J., & O’Brien, P. (2004) · The Journal of Organic Chemistry · doi:10.1021/jo049182w · Cited by 91
Varin, T. V., Schuffenhauer, A., Ertl, P., & Renner, S. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci2000924 · Cited by 81
Self-citationDrugs in other drugs: a new look at drugs as fragments
Siegel, M. G., & Vieth, M. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.11.011 · Cited by 79
The scaffold hopping potential of pharmacophores
Heßler, G., & Baringhaus, K. (2010) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2010.09.001 · Cited by 72
Selectivity of Kinase Inhibitor Fragments
Bamborough, P., Brown, M. J. B., Christopher, J. A., Chung, C., & Mellor, G. W. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200349b · Cited by 71
Informatics and modeling challenges in fragment-based drug discovery.
Hubbard, R. E., Chen, I., & Davis, B. J. (2007) · PubMed · Cited by 61
Using small molecules to target protein phosphatases
Vintonyak, V. V., Waldmann, H., & Rauh, D. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.02.047 · Cited by 51
Self-citationGoettert, M. I., Schattel, V., Koch, P., Merfort, I., & Laufer, S. (2010) · ChemBioChem · doi:10.1002/cbic.201000487 · Cited by 46
Getlik, M., Grütter, C., Simard, J. R., Nguyen, H. D., Robubi, A., Aust, B., van Otterlo, W. A. L., & Rauh, D. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.11.019 · Cited by 40
Self-citationA comparative study of fragment screening methods on the p38α kinase: new methods, new insights
Pollack, S. J., Beyer, K. S., Lock, C., Müller, I., Sheppard, D. W., Lipkin, M., HARDICK, D. J., Blurton, P., Leonard, P. M., Hubbard, P. A., et al. (2011) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-011-9454-9 · Cited by 34
Fragment Shuffling: An Automated Workflow for Three-Dimensional Fragment-Based Ligand Design
Nisius, B., & Rester, U. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci8004572 · Cited by 21
Cited by
Natural products as sources of new drugs from 1981 to 2014
Newman, D. J., & Cragg, G. M. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b01055 · Cited by 5,858
Brown, D. G., & Boström, J. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01409 · Cited by 1,964
Counting on natural products for drug design
Rodrigues, T., Reker, D., Schneider, P., & Schneider, G. (2016) · Nature Chemistry · doi:10.1038/nchem.2479 · Cited by 1,250
Twenty years on: the impact of fragments on drug discovery
Erlanson, D. A., Fesik, S. W., Hubbard, R. E., Jahnke, W., & Jhoti, H. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.109 · Cited by 1,000
The application of in silico drug-likeness predictions in pharmaceutical research
Tian, S., Wang, J., Li, Y., Li, D., Xu, L., & Hou, T. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.01.009 · Cited by 498
Metadata
- Authors
- Over, B., Wetzel, S., Grütter, C., Nakai, Y., Renner, S., Rauh, D., & Waldmann, H.
- Venue
- Nature Chemistry
- Published
- 2012-12-02
- Volume
- 5
- Issue
- 1
- Pages
- 21-28
- ISSN
- 1755-4330 (ISSN-L)
- 1755-4349
- OpenAlex
- W1980862340
- Cited by
- 300
- References
- 42
- FWCI
- 26.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.